Sign in
CompletedNo phase

Augmented Reality to Support Cardiopulmonary Resuscitation

Key facts

Who runs it
Johan Siebert, MD
Where
Canada and Switzerland2 sites in 2 countriesChoose a country to see its sites
Trial code
Status
Completed
People taking part
54 people enrolled
Started
2 Apr 2025
Ended
1 Jul 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Augmented reality supportive tool
  • Conventional method (AHA pocket reference card)
Record updated
19 August 2025

Who can take part

Age
18 years to 70 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Inclusion criteria for the team leader include: attending physician, fellow, or senior resident in emergency medicine, pediatric emergency medicine, pediatrics, pediatric critical care, or pediatric anesthesia
  • Inclusion criteria for the medication and charting nurse roles include: nurse in pediatric emergency medicine, general pediatrics, or other pediatric acute care specialty
  • Inclusion criteria for all other team members include: pediatric attending physician, resident, fellow, nurse or respiratory therapist
  • Participants must have prior basic life support training
  • Participation agreement

Who cannot take part

  • Previously enrolled
  • Decline to provide informed consent
  • Unable to perform tasks required of the role

This trial has no sites in United States.

It has sites in 2 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

A prospective, multicenter, randomized clinical trial in two tertiary pediatric emergency department. It will assess, amongst pediatric healthcare teams, whether the use of augmented reality supportive devices improves adherence to American Heart Association (AHA) advanced life support guidelines and performance, while reducing medication errors, when compared to groups using the AHA pocket reference card (control) during standardized, simulation-based, pediatric in-hospital cardiac arrest (IHCA) scenarios. Seventy participants will be randomized. The primary endpoint is the time to first dose of epinephrine.

The 2 groups in the trial

  • Arm A (Augmented Reality)Treatment being tested

    Participants that will use the augmented reality supportive tool during the simulation-based pediatric scenario.

    Treatment: Augmented reality supportive tool

  • Arm B (Conventional methods)Existing treatment, for comparison

    Participants that will use conventional methods during the simulation-based pediatric scenario.

    Treatment: Conventional method (AHA pocket reference card)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Evaluation of an Augmented Reality and Screen-based Decision Support System for Cardiopulmonary Arrest: a Multicenter, Randomized Clinical Trial
Publications
Record updated
19 August 2025